04-Mar-2010 - New Synthemax synthetic growth matrix promises improved scalability for large-scale hESC production which, say developers Geron and Corning, will cut cost of cell therapy manufacture.
03-Mar-2010 - The US FDA wants to boost the production of cell-based viral vaccines and says new guidance will help manufacturers.
03-Mar-2010 - Bayer Technology Services (BTS) has set up a new Singapore office to provide the regions’ drug and chemicals producers with engineering consultation services and micro reaction technology.
01-Mar-2010 - iBio has agreed in principle to license its iBioLaunch platform, which uses Nicotiana to produce therapeutics, to G-Con for the development and manufacture of plant-expressed influenza vaccines.
01-Mar-2010 - German pharmaceutical firm Merck KGaA says proposed Millipore acquisition will transform its chemicals unit and give it a more balanced business profile.
25-Feb-2010 - SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.
18-Feb-2010 - US group Waters and Japan’s Daiso team up to market bulk process chromatography media and say deal provides the supply stability drug industry demands.
15-Feb-2010 - GEA Niro says new spray drying deal with BASF is an important step in the development of its recently established contract API manufacturing unit.
03-Feb-2010 - Demand for disposable bioprocessing tech helped Millipore to a comfortable Q4, cementing the recovery made by the unit throughout 2009.
03-Feb-2010 - Pall Life Sciences plans to shake up bioprocessing with a vibration-based filtering tech that can cut costs and simplify process design by combining harvest and clarification in the same system.
27-Jan-2010 - Environmental certification of production facilities should be introduced to GMP legislation and sustainability risk assessments linked to marketing authorisations, according to a MPA report.
21-Jan-2010 - Pharmaceutical packaging machinery manufacturer Sepha has reported a 33 per cent increase in sales for 2009, underpinned by strong growth in Asia and South America.
20-Jan-2010 - Ranbaxy Laboratories has strengthened its vaccine and biologics manufacturing capabilities by acquiring India-based Biovel Lifesciences.
13-Jan-2010 - Pall says its acquisition of MicroReactor Technologies (MRT) broadens its offering in the $1bn (€689m) a year global biopharmaceutical process development market.
13-Jan-2010 - Novavax has completed cGMP scale up of its RSV-F vaccine candidate, with the material being used in preclinical studies, and amended the terms of the H1N1 collaboration with Xcellerex.
12-Jan-2010 - Millipore wants to help biopharmas address “virus safety challenges” and believes its new Viresolve Pro+ filtration system may provide the solution.
11-Jan-2010 - Vaccines could be produced in less than 10 weeks from first isolation of the RNA sequence by using insect cell derived influenza VLPs, according to research which has implications for H1N1 and H5N1.
09-Dec-2009 - Teva will continue to use Codexis’ biocatalysis technology for key processing steps in the production of four generic drugs under a revised agreement announced last week.
02-Dec-2009 - Cell culture solutions provider Vivalis will be listed on the French stock exchange’s CAC Small 90 and SBF 250 indices from December 21.
02-Dec-2009 - Sartorius Stedim Biotech has introduced FlexAct BP, the first product in a range which will be an integrated single-use system for entire biomanufacturing steps in upstream and downstream processing.
01-Dec-2009 - Leeds University in the UK has unveiled a new £4m (€4.4m) laboratory designed to make small-scale process development “greener, cheaper and more effective.”
30-Nov-2009 - Sanofi-Aventis plans to participate with a Russian state-owned corporation in a project to attract innovative drug manufacturers to the country, using its insulin facility as a pilot initiative.
26-Nov-2009 - SAFC Biosciences hopes Ex-Cell Antifoam, its new foam control product for cell culture bioreactors, will work the biomanufacturing sector into a lather.
24-Nov-2009 - Millipore has acquired the remaining 60 per cent of its Indian joint venture (JV) to drive growth in the country which it views, along with the other BRICS nations, as a critical part of its strategy.
23-Nov-2009 - GEA Pharma Systems has extended its agency agreement with India’s Ace Technologies to include its range of lyophil freeze-dryers in a bid to further open up the market.